Osimertinib: Another medication related to osteonecrosis of the jaws? A case report and literature review

• Main Authors: Feng Wang (Author), Shengnan Wei (Author), Zexuan Zhang (Author), Yuan Zhang (Author), Jingya He (Author), Bin Sun (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is an oral complication in cancer patients being treated with either antiresorptives, mainly denosumab and bisphosphonates, or antiangiogenic drugs. Osimertinib is a third-generation epidermal growth factor receptor (EGFR)-tyrosine ki...